// App-Quantinova.ai

P215 : Filgotinib, a janus kinase 1 selective inhibitor, modulates disease-associated cytokines in patients with active RA

Researchers

Presenter

  • Peter C Taylor

Principal Investigators

  • Emon Elboudwarej

  • Wanying Li

  • Rachael E Hawtin

  • Jinfeng Liu

  • Amer M Mirza

Medical Centers

  • Orthopaedics, Rheumatology & Musculoskeletal Sciences, Botnar Research Centre, Oxford, UNITED KINGDOM

  • Biostatistics, Gilead Sciences, Inc, Foster City, CA

  • Inflammation and Respiratory Therapeutics, Gilead Sciences, Foster City, CA

  • Biomarkers, Gilead Sciences, Foster City, CA

Locations

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Filgotinib

Outcome

  • N/A

Study Design

  • N/A

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved